![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](sj2359contents.gif)
Acta Cryst. (2007). E63, m2630 [ doi:10.1107/S1600536807046764 ]
-5-(pyrazin-2-yl)tetrazol-1-ido]bis[azido(2,2'-bipyridine)copper(II)]Abstract: The title compound, [Cu2(C5H3N6)2(N3)2(C10H8N2)2], consists of isolated neutral centrosymmetric dinuclear units. Each molecule comprises two Cu atoms, two 2-tzpz- ligands [2-Htzpz = 2-(1H-tetrazol-5-yl)pyrazine], two 2,2'-bipyridine (bpy) ligands and two azide groups. The 2-tzpz- ligand is tridentate, utilizing N atoms from the tetrazole and pyrazine rings to chelate to one Cu2+ ion and a second tetrazole N atom to form a bridge to the second Cu2+ ion. The coordination geometry about each Cu2+ center is slightly distorted octahedral. The crystal packing is stabilized by intermolecular C-H
N hydrogen bonds.
Online 29 September 2007
Copyright © International Union of Crystallography
IUCr Webmaster